High Clinical Value of Liquid Biopsy to Detect Circulating Tumor Cells and Tumor Exosomes in Pancreatic Ductal Adenocarcinoma Patients Eligible for Up-Front Surgery

被引:105
作者
Buscail, Etienne [1 ,2 ,3 ]
Alix-Panabieres, Catherine [4 ]
Quincy, Pascaline [1 ,2 ,3 ]
Cauvin, Thomas [1 ,2 ,3 ]
Chauvet, Alexandre [1 ,2 ,3 ]
Degrandi, Olivier [1 ,2 ,3 ]
Caumont, Charline [2 ,3 ]
Verdon, Severine [2 ]
Lamrissi, Isabelle [1 ,3 ]
Moranvillier, Isabelle [1 ,3 ]
Buscail, Camille [5 ]
Marty, Marion [2 ]
Laurent, Christophe [1 ,2 ,3 ]
Vendrely, Veronique [1 ,2 ,3 ]
Moreau-Gaudry, Francois [1 ,2 ,3 ]
Bedel, Aurelie [1 ,2 ,3 ]
Dabernat, Sandrine [1 ,2 ,3 ]
Chiche, Laurence [1 ,2 ,3 ]
机构
[1] INSERM, U1035, F-33000 Bordeaux, France
[2] CHU Bordeaux, F-33000 Bordeaux, France
[3] Univ Bordeaux, F-33076 Bordeaux, France
[4] Univ Med Ctr Montpellier, Lab Rare Human Circulating Cells, EA2415 Montpellier, Montpellier, France
[5] Paris 13 Univ, Nutr Epidemiol Res Team EREN, INSERM, INRA,CNAM,U1153,U1125,Paris Cite Epidemiol & Stat, F-93017 Bobigny, France
关键词
pancreatic cancer; liquid biopsy; exosomes; circulating tumor cells; PORTAL-VEIN; CANCER; DNA; EPIDEMIOLOGY; METASTASES; BLOOD; LIVER;
D O I
10.3390/cancers11111656
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Expediting the diagnosis of pancreatic ductal adenocarcinoma (PDAC) would benefit care management, especially for the start of treatments requiring histological evidence. This study evaluated the combined diagnostic performance of circulating biomarkers obtained by peripheral and portal blood liquid biopsy in patients with resectable PDAC. Experimental design: Liquid biopsies were performed in a prospective translational clinical trial (PANC-CTC #NCT03032913) including 22 patients with resectable PDAC and 28 noncancer controls from February to November 2017. Circulating tumor cells (CTCs) were detected using the CellSearch (R) method or after RosetteSep (R) enrichment combined with CRISPR/Cas9-improved KRAS mutant alleles quantification by droplet digital PCR. CD63 bead-coupled Glypican-1 (GPC1)-positive exosomes were quantified by flow cytometry. Results: Liquid biopsies were positive in 7/22 (32%), 13/22 (59%), and 14/22 (64%) patients with CellSearch (R) or RosetteSep (R)-based CTC detection or GPC1-positive exosomes, respectively, in peripheral and/or portal blood. Liquid biopsy performance was improved in portal blood only with CellSearch (R), reaching 45% of PDAC identification (5/11) versus 10% (2/22) in peripheral blood. Importantly, combining CTC and GPC1-positive-exosome detection displayed 100% of sensitivity and 80% of specificity, with a negative predictive value of 100%. High levels of GPC1(+)-exosomes and/or CTC presence were significantly correlated with progression-free survival and with overall survival when CTC clusters were found. Conclusion: This study is the first to evaluate combined CTC and exosome detection to diagnose resectable pancreatic cancers. Liquid biopsy combining several biomarkers could provide a rapid, reliable, noninvasive decision-making tool in early, potentially curable pancreatic cancer. Moreover, the prognostic value could select patients eligible for neoadjuvant treatment before surgery. This exploratory study deserves further validation.
引用
收藏
页数:17
相关论文
共 49 条
[1]   OPINION Challenges in circulating tumour cell research [J].
Alix-Panabieres, Catherine ;
Pantel, Klaus .
NATURE REVIEWS CANCER, 2014, 14 (09) :623-631
[2]   High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients [J].
Allenson, K. ;
Castillo, J. ;
San Lucas, F. A. ;
Scelo, G. ;
Kim, D. U. ;
Bernard, V. ;
Davis, G. ;
Kumar, T. ;
Katz, M. ;
Overman, M. J. ;
Foretova, L. ;
Fabianova, E. ;
Holcatova, I. ;
Janout, V. ;
Meric-Bernstam, F. ;
Gascoyne, P. ;
Wistuba, I. ;
Varadhachary, G. ;
Brennan, P. ;
Hanash, S. ;
Li, D. ;
Maitra, A. ;
Alvarez, H. .
ANNALS OF ONCOLOGY, 2017, 28 (04) :741-747
[3]  
Cubero MJA, 2017, METHODS MOL BIOL, V1634, P283, DOI 10.1007/978-1-4939-7144-2_24
[4]   Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer [J].
Bernard, Vincent ;
Kim, Dong U. ;
San Lucas, F. Anthony ;
Castillo, Jonathan ;
Allenson, Kelvin ;
Mulu, Feven C. ;
Stephens, Bret M. ;
Huang, Jonathan ;
Semaan, Alexander ;
Guerrero, Paola A. ;
Kamyabi, Nabiollah ;
Zhao, Jun ;
Hurd, Mark W. ;
Koay, Eugene J. ;
Taniguchi, Cullen M. ;
Herman, Joseph M. ;
Javle, Milind ;
Wolff, Robert ;
Katz, Matthew ;
Varadhachary, Gauri ;
Maitra, Anirban ;
Alvarez, Hector A. .
GASTROENTEROLOGY, 2019, 156 (01) :108-+
[5]   Advances in Biomarker Research for Pancreatic Cancer [J].
Bhat, Kruttika ;
Wang, Fengfei ;
Ma, Qingyong ;
Li, Qinyu ;
Mallik, Sanku ;
Hsieh, Tze-chen ;
Wu, Erxi .
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (17) :2439-2451
[6]   Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial [J].
Bidard, F. C. ;
Huguet, F. ;
Louvet, C. ;
Mineur, L. ;
Bouche, O. ;
Chibaudel, B. ;
Artru, P. ;
Desseigne, F. ;
Bachet, J. B. ;
Mathiot, C. ;
Pierga, J. Y. ;
Hammel, P. .
ANNALS OF ONCOLOGY, 2013, 24 (08) :2057-2061
[7]   Portal vein-circulating tumor cells predict liver metastases in patients with resectable pancreatic cancer [J].
Bissolati, Massimiliano ;
Sandri, Maria Teresa ;
Burtulo, Giovanni ;
Zorzino, Laura ;
Balzano, Gianpaolo ;
Braga, Marco .
TUMOR BIOLOGY, 2015, 36 (02) :991-996
[8]   CD63-GPC1-Positive Exosomes Coupled with CA19-9 Offer Good Diagnostic Potential for Resectable Pancreatic Ductal Adenocarcinoma [J].
Buscail, Etienne ;
Chauvet, Alexandre ;
Quincy, Pascaline ;
Degrandi, Olivier ;
Buscail, Camille ;
Lamrissi, Isabelle ;
Moranvillier, Isabelle ;
Caumont, Charline ;
Verdon, Severine ;
Brisson, Alain ;
Marty, Marion ;
Chiche, Laurence ;
Laurent, Christophe ;
Vendrely, Veronique ;
Moreau-Gaudry, Francois ;
Bedel, Aurelie ;
Dabernat, Sandrine .
TRANSLATIONAL ONCOLOGY, 2019, 12 (11) :1395-1403
[9]   Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma [J].
Buscail, Etienne ;
Maulat, Charlotte ;
Muscari, Fabrice ;
Chiche, Laurence ;
Cordelier, Pierre ;
Dabernat, Sandrine ;
Alix-Panabieres, Catherine ;
Buscail, Louis .
CANCERS, 2019, 11 (06)
[10]   Tumor-proximal liquid biopsy to improve diagnostic and prognostic performances of circulating tumor cells [J].
Buscail, Etienne ;
Chiche, Laurence ;
Laurent, Christophe ;
Vendrely, Veronique ;
Denost, Quentin ;
Denis, Jerome ;
Thumerel, Matthieu ;
Lacorte, Jean-Marc ;
Bedel, Aurelie ;
Moreau-Gaudry, Francois ;
Dabernat, Sandrine ;
Alix-Panabieres, Catherine .
MOLECULAR ONCOLOGY, 2019, 13 (09) :1811-1826